Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2702 of 5804
-
Can online therapy and sound ease ringing ears?
Symptom relief CompletedConsidering the lack of evidence on the effects of combining acceptance and commitment therapy (ACT) with customized sound therapy for tinnitus-related insomnia patients, investigators designed this single-blind, 5-months randomized, controlled trial with two parallel groups. One…
Phase: NA • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
CBD oil may soothe itch in kids with rare skin disease
Symptom relief CompletedHereditary epidermolysis bullosa (HEB) is a heterogeneous group of rare genetic diseases, characterized by fragility of the skin and mucous membranes, which results in the appearance of mucocutaneous bullae and erosions during minimal trauma. Pruritus is a neuropathic pain mainly…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Can a diabetes pill calm obesity's hidden fire?
Disease control Recruiting nowObesity is associated with increased cardiometabolic disease risk due, in part, to heightened chronic inflammation arising from adipose tissue. There are no current targeted therapies to prevent or reverse the chronic inflammation of obesity, and a better understanding of these i…
Phase: PHASE1, PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Homeopathic sleep aid neurexan put to the test in insomnia trial
Symptom relief CompletedThis clinical study aims to understand the effects of a medication called Neurexan on sleep patterns and stress in people with short-term insomnia. The study involves comparing Neurexan to a placebo - a tablet that looks like Neurexan but lacks active ingredients. The main goal o…
Phase: PHASE2 • Sponsor: Biologische Heilmittel Heel GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Silicone toe inserts may shield diabetic feet from painful ulcers
Disease control CompletedThe present study aims to evaluate the efficacy and safety of the use of customized silicone digital orthoses for six months in the distribution of plantar pressure, in the reduction of pre-ulcerative lesions and plantar ulcers in the forefoot, foot deformities, quality of life a…
Phase: NA • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Eczema drug SHR-1819 passes extended safety test in 79 patients
Disease control CompletedThis study is a multicenter, open-label, extended study to evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of SHR-1819 injection in adult subjects with moderate to severe atopic dermatitis who have previously participated in the SHR-1819 injection study for at…
Phase: PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New scan could reveal hidden aggression in brain tumors
Knowledge-focused Recruiting nowThe purpose of this project is to validate a new combined MRI and PET imaging technique as a biomarker or measure of glycolysis in brain tumors. To accomplish this, the investigators propose obtaining image-guided measures of tissue pH and biopsied tissue in tumor areas selected …
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New study aims to help cystic fibrosis patients discuss lung transplants earlier
Knowledge-focused OngoingLung transplant is an option for treating end-stage lung disease in cystic fibrosis (CF). In the United States, more people with CF and low lung function die each year than undergo lung transplant. More than half of people with CF who die without a lung transplant were never refe…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Robot + zaps: new combo therapy boosts arm recovery after stroke
Symptom relief CompletedThe purpose of this clinical trial is to investigate the efficacy of a hybrid-based rehabilitation program for the upper extremity(UE) combining the interventions- Functional Electrical Stimulation (FES) and Robotic rehabilitation in individuals with chronic stroke. The main ques…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Health coaching boosts mobility in seniors: new trial
Symptom relief Recruiting nowThe goal of this randomized controlled trial is to investigate the effectiveness of a health-coaching intervention to improve physical activity in older adults with limited mobility when compared to a control, health education group.
Phase: NA • Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Brain tumor radiation: could skipping the safety margin be just as good?
Knowledge-focused Recruiting nowThis is a randomized study to determine if not treating planning target volume (PTV) margins during radiation therapy worsens progression free survival rates in patients with brain metastases.
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Bile duct battle: which backup technique works best?
Knowledge-focused Recruiting nowSelective bile duct cannulation is the most important step in endoscopic retrograde cholangiopancreatography (ERCP) for treatment of benign and malignant pancreatobiliary diseases, but it may fail in up to 15% of cases. Precut papillotomy is an advanced ERCP cannulation technique…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
New pill AUR107 enters first human tests for tough cancers
Disease control Recruiting nowAn open-label, first-in-human, Phase 1 study in adult patients with relapsed advanced malignancies will be done to assess AUR107 safety, tolerability, pharmacokinetics, pharmacodynamics, and optimal biological dose.
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Exercise eases gut and body pain in fibromyalgia and IBS
Symptom relief CompletedThe project focuses on "somatic functional syndrome", a category of disorders characterized by subjective symptoms, suffering and disability without evident organic or functional alterations. Syndromes such as Fibromyalgia, Irritable Bowel, Chronic Fatigue and Restless Legs fall …
Phase: NA • Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Could a spoonful of honey ease Post-Surgery pain?
Symptom relief Recruiting nowDouble-blind, randomised, placebo controlled, single-site trial in adults to compare the effect of Manuka honey with standard of care compared to placebo with standard of care on post-tonsillectomy pain and postoperative outcomes. Main aim is to investigate a potential improveme…
Phase: NA • Sponsor: East and North Hertfordshire NHS Trust • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Electric sleeve aims to steady MS Patients' steps
Symptom relief Recruiting nowThe purpose of this research is to support the clinical value of the Cionic Neural Sleeve for individuals diagnosed with multiple sclerosis (MS).
Phase: NA • Sponsor: Cionic, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Experimental drug BL-M02D1 takes on tough lung cancers
Disease control OngoingPhase Ib: To explore the safety and preliminary efficacy of BL-M02D1 to further define RP2D in a variety of solid tumors such as locally advanced or metastatic non-small cell lung cancer. Phase II: To explore the efficacy of BL-M02D1 using single-agent RP2D obtained from phase I …
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a hypnosis app help kids with ADHD focus and feel less anxious?
Symptom relief CompletedThe prevalence of Attention Deficit/ Hyperactivity (ADHD) varies between 3 and 10% depending on the studies. Comorbidities are frequently associated, in particular anxiety disorders. School, social and family consequences of ADHD can be major, especially in the presence of a como…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 26, 2026 16:45 UTC
-
App eases psoriasis burden in landmark trial
Symptom relief CompletedThis clinical trial with 348 patients with psoriasis aims to investigate the effectiveness of a self-guided online program for patients with psoriasis. Patients will be randomized and allocated in a 1:1 ratio to either an intervention group, in which they will receive 12-month-a…
Phase: NA • Sponsor: Gaia AG • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can exercise and diet beat muscle loss in seniors? new study says maybe
Disease control CompletedThis is an empirical study, which aims to examine the effect of a 12-week combined exercise-nutrition intervention in older adults with sarcopenia and to provide data for clinical and policy decision-making of sarcopenia. The study conducts the combined exercise-nutrition interve…
Phase: NA • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:47 UTC